| Literature DB >> 29451051 |
Larry E Miller1, Joseph S Gondusky2, Atul F Kamath3, Friedrich Boettner4, John Wright5, Samir Bhattacharyya5.
Abstract
Background and purpose - Systematic comparisons of anterior approach (A) versus posterior approach (P) in primary total hip arthroplasty (THA) have largely focused on perioperative outcomes. In this systematic review with meta-analysis, we compared complication risk of A versus P in studies of primary THA with at least 1-year mean follow-up. Patients and methods - We performed a systematic review of prospective and retrospective studies with at least 1-year mean follow-up that reported complications of A and P primary THA. Complications included infection, dislocation, reoperation, thromboembolic event, heterotopic ossification, wound complication, fracture, and nerve injury. Random effects meta-analysis was used for all outcomes. Complication risk was reported as rate ratio (RR) to account for differential follow-up durations; values >1 indicated higher complication risk with A and values <1 indicated lower risk with A. Results - 19 studies were included; 15 single-center comparative studies with 6,620 patients (2,278 A; 4,342 P) and 4 multicenter registries with 157,687 patients (18,735 A; 138,952 P). Median follow-up was 16 (12-64) months) with A and 18 (12-110) months with P. Anterior approach was associated with lower rate of infection (RR =0.55, p = 0.002), dislocation (RR =0.65, p = 0.03), and reoperation (RR =0.84, p < 0.001). No statistically significant differences were observed in rate of thromboembolic event (RR =0.59, p = 0.5), heterotopic ossification (RR =0.63, p = 0.1), wound complication (RR =0.93, p = 0.8), or fracture (RR =1.0, p = 0.9). There was a higher rate of patient-reported nerve injury with A (RR =2.3, p = 0.01). Interpretation - Comparing A with P in primary THA, A was associated with lower risk of reoperation, dislocation, and infection, but higher risk of patient-reported nerve injury.Entities:
Mesh:
Year: 2018 PMID: 29451051 PMCID: PMC6055783 DOI: 10.1080/17453674.2018.1438694
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Study and patient characteristics
| Study | Treatment | Parallel treatment | Learning cases | Mean follow-up,months | Sample size | Mean age,years | Female, % | Mean BMI | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | design | period | period | included | A | P | A | P | A | P | A | P | A | P |
| Comparative studies: | ||||||||||||||
| Balasubramaniam et al. | RN | 2006–2011 | No | Yes | 12 | 12 | 50 | 42 | 63 | 57 | 50 | 67 | 31 | 30 |
| Barrett et al. | RCT | 2010–2011 | Yes | No | 12 | 12 | 43 | 44 | 61 | 63 | 33 | 57 | 31 | 29 |
| Batailler et al. | RN | 2013–2015 | Yes | Yes | 14 | 14 | 201 | 101 | 72 | 74 | 65 | 65 | 26 | 28 |
| Fransen et al. | RN | 2012 | Yes | Yes | 12 | 12 | 45 | 38 | 64 | 63 | 67 | 63 | 25 | 28 |
| Luo et al. | RCT | 2014 | Yes | No | 14 | 14 | 52 | 52 | 62 | 64 | 67 | 58 | 23 | 24 |
| Malek et al. | RN | 2010–2014 | Yes | No | 18 | 18 | 265 | 183 | 71 | 70 | 56 | 53 | 29 | 29 |
| Newman et al. | RN | – | NR | NR | 24 | 24 | 235 | 120 | 63 | 59 | 54 | 57 | 29 | 34 |
| Rathod et al. | RN | 2007–2011 | No | No | 16 | 30 | 286 | 293 | 62 | 61 | 55 | 57 | 26 | 26 |
| Rodriguez et al. | PN | 2010 | Yes | No | 12 | 12 | 60 | 60 | 60 | 59 | 53 | 57 | 27 | 28 |
| Sugano et al. | RN | 2005–2007 | No | NR | 24 | 24 | 33 | 39 | 56 | 57 | 88 | 92 | 23 | 23 |
| Taunton et al. | RCT | 2012 | Yes | No | 12 | 12 | 27 | 27 | 62 | 66 | 56 | 52 | 28 | 29 |
| Tripuraneni et al. | RN | 2012–2015 | Yes | Yes | 14 | 13 | 66 | 66 | 60 | 60 | 61 | 61 | 28 | 28 |
| Tsukada and Wakui | RN | 2000–2009 | No | NR | 64 | 110 | 139 | 177 | 67 | 62 | 90 | 83 | 23 | 24 |
| Watts et al. | RN | 2010–2014 | NR | NR | 12 | 12 | 716 | 3,040 | 64 | 62 | 51 | 51 | 29 | 30 |
| Zhang et al. | RCT | 2002–2004 | Yes | NR | 20 | 20 | 60 | 60 | 61 | 63 | 58 | 53 | – | – |
| Registries | ||||||||||||||
| Amlie et al. | RN | 2008–2010 | Yes | No | 24 | 30 | 421 | 421 | 67 | 66 | 69 | 64 | – | – |
| Mjaaland et al. | RN | 2008–2013 | Yes | Yes | 52 | 52 | 2,017 | 5,961 | 67 | 65 | 67 | 65 | – | – |
| Sheth et al. | RN | 2001–2011 | No | Yes | 36 | 36 | 1,851 | 31,747 | 65 | 66 | 60 | 58 | 28 | 29 |
| Zijlstra et al. | RN | 2007–2015 | No | Yes | 40 | 40 | 14,446 | 100,823 | – | – | 68 | 68 | – | – |
A = anterior approach; P = posterior approach; NR = not reported
Study design: PN = prospective nonrandomized; RCT = randomized controlled trial; RN = retrospective nonrandomized.
Reported as number of patients or hips.
All patients with BMI ≤27 kg/m2.
Cochrane risk of bias assessment
Complication rates with anterior versus posterior approach in primary total hip arthroplasty
| Event rate per 100 person-years | |||||||
|---|---|---|---|---|---|---|---|
| Outcome | Studies | A | P | Effect size Rate ratio (95% CI) | p-value | Heterogeneity (I2), % | Publication bias (Egger’s p-value) |
| Infection | 7 | 0.2 | 0.4 | 0.55 (0.38–0.80) | 0.002 | 0 | 0.5 |
| Thromboembolic event | 4 | 0.5 | 1.1 | 0.59 (0.14–2.43) | 0.5 | 0 | 0.2 |
| Heterotopic ossification | 4 | 1.5 | 2.3 | 0.63 (0.35–1.13) | 0.1 | 0 | 0.3 |
| Dislocation | 11 | 0.2 | 0.2 | 0.65 (0.44–0.95) | 0.03 | 17 | 0.5 |
| Reoperation | 16 | 0.6 | 0.7 | 0.84 (0.75–0.93) | < 0.001 | 0 | 1.0 |
| Wound | 5 | 1.7 | 1.9 | 0.93 (0.54–1.63) | 0.8 | 0 | 0.4 |
| Fracture | 10 | 0.3 | 0.1 | 1.02 (0.75–1.38) | 0.9 | 0 | 0.2 |
| Patient-reported nerve injury | 2 | 3.0 | 1.3 | 2.31 (1.22–4.39) | 0.01 | 0 | |
Notes: A = anterior approach; P = posterior approach.
Rate ratio >1 indicates higher complication incidence rate with anterior approach; rate ratio <1 indicates lower complication incidence rate with anterior approach.
Inadequate number of studies to calculate value.
Subgroup analysis of study design on complication rates with anterior versus posterior approach in primary total hip arthroplasty
| Comparative studies | Registries | ||||
|---|---|---|---|---|---|
| Outcome | Studies | Rate ratio (95% CI) | Studies | Rate ratio (95% CI) | p-value |
| Infection | 6 | 0.66 (0.16–2.7) | 1 | 0.55 (0.37–0.80) | 0.8 |
| Thromboembolic event | 4 | 0.59 (0.14–2.4) | 0 | – | – |
| Heterotopic ossification | 3 | 0.58 (0.30–1.2) | 1 | 0.81 (0.24–2.7) | 0.6 |
| Dislocation | 8 | 0.55 (0.17–1.8) | 3 | 0.74 (0.39–1.4) | 0.7 |
| Reoperation | 12 | 1.03 (0.60–1.8) | 4 | 0.83 (0.72–0.95) | 0.5 |
| Wound | 5 | 0.93 (0.54–1.6) | 0 | – | – |
| Fracture | 9 | 1.7 (0.79–3.7) | 1 | 0.93 (0.66–1.3) | 0.2 |
| Patient-reported nerve injury | 1 | 5.0 (0.24–104) | 1 | 2.2 (1.2–4.3) | 0.6 |
Rate ratio >1 indicates higher complication incidence rate with anterior approach; RR <1 indicates lower complication incidence rate with anterior approach.
Comparison of rate ratio in comparative studies versus registries, derived from Knapp– Hartung random effects meta-regression model.